A call for individualized approaches to tuberculosis screening practices among new users of biologic or targeted synthetic disease‐modifying antirheumatic drugs: comment on the article by Roberts et al
Yuting Wang, Guiyao Jin, Wenlong Wang, Fanzhang Meng, Chen Li
Arthritis Care & Research · 2025-04
Abstract
Disclosure Form Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
MeSH terms
- Antirheumatic drugs
- Tuberculosis
- Medicine
- Disease
- Antirheumatic Agents
- Intensive care medicine